| Date | Event | Reminder | | No Upcoming Events |
|
| Date | Event | | 30-Nov-09 | SCOLR PHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard | | 25-Nov-09 | SCOLR PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement | | 9-Nov-09 | SCOLR PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi | | 6-Nov-09 | SCOLR PHARMA, INC. Files SEC form 10-Q, Quarterly Report | | 3-Nov-09 | SCOLR PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits | | 18-Sep-09 | SCOLR PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definiti | | 1-Sep-09 | SCOLR PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal O | | 7-Aug-09 | SCOLR PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi | | 29-Jun-09 | SCOLR PHARMA, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard | | 29-May-09 | SCOLR PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits | | 1-May-09 | SCOLR PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi | | 25-Mar-09 | SCOLR PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers | | 17-Mar-09 | Price hit new 52-week low ($0.25) | | 16-Mar-09 | Price hit new 52-week low ($0.32) | | 11-Mar-09 | SCOLR PHARMA, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi | | 5-Mar-09 | Price hit new 52-week low ($0.36) | | 5-Feb-09 | SCOLR PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal O | | 16-Dec-08 | SCOLR PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits | | 11-Dec-08 | SCOLR PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers |
|
| |
|